Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Test product: KSM 66 Ashwagandha Capsule (300 mg), orally twice a day for 12 weeks
Control Intervention1: Control Product: 300 mg Placebo capsule identical to KSM 66 Ashwagandha but wit
Sponsors
D Y Patil Medical College Hospital and Research Center
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of either gender, aged 18 to 50 years 2. All adult patients aged >=18 years who present to the site for follow-up OPD 3. Laboratory-confirmed COVID-19 infection with SARS-CoV-2 4. Patients who agree to follow-up for up to six months. 5. Subjects able to understand and complete the study questionnaires 6. Subjects who sign the informed written consent
Exclusion criteria
Exclusion criteria: 1. Patients aged below 18 years will be excluded. 2. Unwilling or unable to provide written informed consent, 3. Pregnant or breast-feeding women or women with positive urinary pregnancy test at screening. 4. Those who cannot be relied upon to comply with the test procedures or are unwilling to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the health summary scores from Short Form SF-36 Quality of life questionnaire at the end of 12 weeks Timepoint: screening, week 4, week 8 and week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in scores for HAM-A at the end of 12 weeksTimepoint: screening, week 4, week 8 and week 12;Change in scores for HAM-D at the end of 12 weeks Timepoint: screening, week 4, week 8 and week 12 | — |
Countries
India
Contacts
Public ContactDr Deepak Langade
D Y Patil Medical College, Hospital and Research Center
Outcome results
None listed